EMA releases joint strategy for regulatory agencies to 2025
The European Medicines Agency (EMA) and Heads of Medicines Agencies (HMA) have published their joint strategy for the next five … read more »
EFPIA releases statement on meeting of EU Health Ministers
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has released a statement on the EU Pharmaceutical Strategy published last … read more »
UK strategy for rare diseases: 2020 update published
The 2020 update to the Government’s strategy for rare diseases has been published, explaining progress made to date and the … read more »
Kings Fund release new strategy for 2020-2024
The Kings Fund has launched its new strategy document explaining its focusses for this five-year period. The Kings Fund is … read more »
MHRA Publishes Business Plan for 2019-20
The 2019-20 Business Plan for the Medicines and Healthcare Products Regulatory Agency (MHRA) has been published, explaining the Agency’s goals … read more »
DHSC publishes 2019 update for rare disease strategy plan
The Department of Health and Social Care (DHSC) has published its 2019 update for the UK strategy for rare diseases. … read more »
AWMSG consultation on its Five Year Strategy
The All Wales Medicines Strategy Group (AWMSG) has opened a consultation on its Five Year Strategy 2018-2023. The AWMSG is … read more »
Industrial Strategy White Paper for life sciences – 27th November 2017
The Government has published its Industrial Strategy White Paper and given further information on the Life Science Sector Deal that will be published … read more »
Welsh Government Unveils Five Year Plan
The First Minister has today unveiled the Welsh Government’s five year plan for Wales. Introduce a New Treatment Fund to give … read more »
